LSV Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.6M Sell
3,737,036
-3,522,694
-49% -$42.1M 0.09% 236
2026
Q1
$43.5M Sell
7,259,730
-212,699
-3% -$1.6M 0.09% 231
2025
Q4
$53.6M Sell
7,472,429
-362,111
-5% -$2.86M 0.12% 211
2025
Q3
$83.7M Sell
7,834,540
-154,920
-2% -$1.52M 0.18% 159
2025
Q2
$77.3M Buy
7,989,460
+8,685
+0.1% +$89.6K 0.18% 159
2025
Q1
$119M Buy
7,980,775
+455,699
+6% +$7.01M 0.29% 113
2024
Q4
$112M Buy
7,525,076
+30,557
+0.4% +$498K 0.26% 122
2024
Q3
$143M Buy
7,494,519
+883,751
+13% +$18.3M 0.31% 116
2024
Q2
$137M Buy
6,610,768
+2,121,940
+47% +$42.2M 0.3% 113
2024
Q1
$84.4M Buy
4,488,828
+1,139,249
+34% +$19.6M 0.17% 161
2023
Q4
$48.3M Buy
3,349,579
+317,727
+10% +$4.32M 0.11% 223
2023
Q3
$52.6M Buy
3,031,852
+251,400
+9% +$5.24M 0.12% 207
2023
Q2
$57.9M Buy
2,780,452
+72,773
+3% +$1.58M 0.13% 205
2023
Q1
$63.7M Buy
2,707,679
+161,960
+6% +$4.35M 0.14% 190
2022
Q4
$71.1M Buy
2,545,719
+4,086
+0.2% +$104K 0.16% 178
2022
Q3
$59.5M Buy
2,541,633
+681,083
+37% +$20.6M 0.14% 179
2022
Q2
$62.8M Buy
1,860,550
+658,351
+55% +$23.1M 0.14% 180
2022
Q1
$42M Buy
1,202,199
+110,214
+10% +$3.77M 0.08% 242
2021
Q4
$33.3M Buy
1,091,985
+97,270
+10% +$3.17M 0.06% 280
2021
Q3
$32.6M Sell
994,715
-48,202
-5% -$1.54M 0.06% 289
2021
Q2
$31.6M Buy
+1,042,917
New +$34.3M 0.05% 301

Other funds holding OGN

LSV Asset Management's OGN Position: Q2 2026 in Review

LSV Asset Management reduced its Organon & Co (OGN) stake by 49% in Q2 2026, selling an estimated $42.1M and leaving 3,737,036 shares worth $50.6M. The position accounts for 0.09% of the portfolio, ranked #236.

LSV Asset Management first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $143M in Q3 2024. 359 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • LSV Asset Management held 3,737,036 shares of Organon & Co worth $50.6M as of Q2 2026.
  • LSV Asset Management sold 3,522,694 Organon & Co shares in Q2 2026, an estimated $42.1M.
  • Organon & Co made up 0.09% of LSV Asset Management's portfolio in Q2 2026, its #236 holding.
  • LSV Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • LSV Asset Management's Organon & Co position peaked at $143M in Q3 2024.
  • 359 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.